- Home
- TRML vs ESRT Comparison
TRML vs ESRT Comparison
Compare TRML & ESRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRML
- ESRT
- Stock Information
- Founded
- TRML 2021
- ESRT 2011
- Country
- TRML United States
- ESRT United States
- Employees
- TRML N/A
- ESRT N/A
- Industry
- TRML Biotechnology: Pharmaceutical Preparations
- ESRT Real Estate Investment Trusts
- Sector
- TRML Health Care
- ESRT Real Estate
- Exchange
- TRML Nasdaq
- ESRT Nasdaq
- Market Cap
- TRML 1.2B
- ESRT 1.2B
- IPO Year
- TRML N/A
- ESRT 2013
- Fundamental
- Price
- TRML $47.97
- ESRT $7.80
- Analyst Decision
- TRML Hold
- ESRT Hold
- Analyst Count
- TRML 12
- ESRT 2
- Target Price
- TRML $47.04
- ESRT $10.65
- AVG Volume (30 Days)
- TRML 657.3K
- ESRT 1.7M
- Earning Date
- TRML 11-13-2025
- ESRT 10-29-2025
- Dividend Yield
- TRML N/A
- ESRT 1.80%
- EPS Growth
- TRML N/A
- ESRT N/A
- EPS
- TRML N/A
- ESRT 0.24
- Revenue
- TRML N/A
- ESRT $763,746,000.00
- Revenue This Year
- TRML N/A
- ESRT $2.27
- Revenue Next Year
- TRML N/A
- ESRT $3.04
- P/E Ratio
- TRML N/A
- ESRT $32.48
- Revenue Growth
- TRML N/A
- ESRT 1.14
- 52 Week Low
- TRML $11.56
- ESRT $6.56
- 52 Week High
- TRML $48.27
- ESRT $11.43
- Technical
- Relative Strength Index (RSI)
- TRML 90.29
- ESRT 59.17
- Support Level
- TRML $47.88
- ESRT $7.10
- Resistance Level
- TRML $48.00
- ESRT $7.46
- Average True Range (ATR)
- TRML 0.05
- ESRT 0.21
- MACD
- TRML -0.84
- ESRT 0.04
- Stochastic Oscillator
- TRML 83.78
- ESRT 89.74
About TRML Tourmaline Bio Inc.
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.
About ESRT Empire State Realty Trust Inc.
Empire State Realty Trust operates as a pure-play greater New York and Manhattan-focused REIT, featuring its landmark Empire State Building office and observation deck. The company owns and operates around 8.5 million square feet of office space, about 80% of which is located in Manhattan.